Tuesday, December 14, 2021
Flaunting It.
While one might be cautious about flaunting a rocket launch that has yet to take place, there are no second thoughts on medicines that have been shown to work. Thus, Pfizer broadly published final data on a new pill to alleviate COVID symptoms. It has been shown to be 89% effective in double-blind testing. Pfizer has now shared its data with the FDA and is looking forward to full approval for its use. It is a significant breakthrough in combating the pandemic. Pfizer deserves the honor and reputation it will reap. It is the best PR and puts the pharma on another level among its peers. The company can rightly claim the prowess of its R&D and its science. That will boost its stock price and embed its name with consumers the world over. Kudos.
Post a Comment